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ABSTRACT 
A superparamagnetic graphene-based magnetite nanocomposite (rGO-Fe3O4) was synthesized 
via a simple in-situ chemical approach. This rGO-Fe3O4 nanocomposite can be used as a drug 
carrier that is able to be guided by external magnetic fields to the specific site of interest for 
targeted drug delivery application to treat cancer. Ganoderma lucidum extract (GL) was 
employed, which successfully stabilized the rGO-Fe3O4 via hydrogen bonding and resulted in 
enhancement of water dispersibility and stability of the prepared nanocomposite, while 
Pluronic F-127 (PF) was introduced to reduce the overall cytotoxicity. The presence of both 
GL and PF on the surface of nanocomposite was successfully validated by cyclic voltammetry 
(CV). Quercetin (Que), a naturally-available polyphenolic flavonoid with anti-cancer 
properties was utilized to study the potential of rGO-Fe3O4-GL-PF for controlled drug delivery 
application. The loading capacity of Que on rGO-Fe3O4-GL-PF was determined to be 11 wt% 
through UV–visible spectroscopy. The Que was loaded on rGO plane via π-π stacking and 
hydrophobic interaction, which was validated through CV. Furthermore, the in-vitro 
cytotoxicity of the synthesized nanocomposite showed obvious cytotoxicity toward A549 cells 
due to the anti-cancer properties of GL which has high potential to be developed into a targeted 
drug delivery carrier for cancer therapeutics. 
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